Yoong Ying Tan
CIK: 0002124360
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GDTC
CytoMed Therapeutics Ltd
Officer
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About TAN YOONG YING
TAN YOONG YING (SEC CIK 0002124360) files insider reports with the SEC as Chief Corporate Officer of CytoMed Therapeutics Ltd (GDTC).
Signal8 holds 1 ownership filing by TAN YOONG YING, a Form 3, filed on May 15, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on TAN YOONG YING's filings is in SINGAPORE.
Other insiders filing for CytoMed Therapeutics Ltd (GDTC)
- Choo Chee Kong, Director
- Toh Keng Kiat, Director
- Yew Chak Hua, Director
- Leong Mark Kei Wei, Director
- Goh Yvonne, Chief Financial Officer